Most Favoured Nation (MFN) pricing has quickly become one of the most talked-about developments in US healthcare policy. But beyond the headlines, what does it actually mean for global pricing and, more importantly, for launch planning and execution?
In this 45-minute webinar, experts from Access Infinity cut through the noise to explore what MFN could mean in practice. Drawing on insights from both US and European markets, they highlight where the real risks lie for global teams and outline what actions you can take now to stay ahead.
Watch the recording and get a clearer view of how different policy scenarios could play out and what they mean for your pricing across markets, launch sequencing, and overall strategy.
Continue your learning about Market Access and Payers
If you’d like to learn more from Louisa and Megan, CELforPharma also offers two 1-day, hands-on courses that will get you up the learning curve quickly!
Understanding Pharma Market Access in the US
With Dr Nick Proctor & Louisa Oliver Byrne
Understanding Pharma Market Access & Payers in Europe
With Dr Nick Proctor & Megan O'Brien
Don’t miss future CELforPharma webinars
Subscribe to our newsletter to:
- Receive invitations to upcoming educational webinars
- Stay on top of the latest expert insights
- Get updates on our courses and training programmes